{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:13:06Z","timestamp":1790363586052,"version":"4.1.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012495","name":"Spondylitis Association of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012495","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.berh.2019.01.002","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T08:57:46Z","timestamp":1551862666000},"page":"369-389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Cardiovascular morbidity and mortality in ankylosing spondylitis and psoriatic arthritis"],"prefix":"10.1016","volume":"32","author":[{"given":"Jean W.","family":"Liew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Ramiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne S.","family":"Gensler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2019.01.002_bib1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.berh.2016.10.006","article-title":"Cardiovascular disease in inflammatory rheumatic diseases","volume":"30","author":"Casta\u00f1eda","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.berh.2019.01.002_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/annrheumdis-2011-201194","article-title":"Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review","volume":"72","author":"Jamnitski","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib4","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/art.1780401021","article-title":"Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death","volume":"40","author":"Wong","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.01.002_bib5","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1002\/art.22800","article-title":"Improved survival in psoriatic arthritis with calendar time","volume":"56","author":"Ali","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.01.002_bib6","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.3899\/jrheum.100034","article-title":"Mortality in psoriatic arthritis - a single-center study from the UK","volume":"37","author":"Buckley","year":"2010","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2019.01.002_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2796.2010.02310.x","article-title":"Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study","volume":"270","author":"Ahlehoff","year":"2011","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.berh.2019.01.002_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/jdv.12163","article-title":"Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review","volume":"27","author":"Horreau","year":"2013","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.berh.2019.01.002_bib9","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/rheumatology\/kew502","article-title":"Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis","volume":"56","author":"Ogdie","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2019.01.002_bib10","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3899\/jrheum.160070","article-title":"Disease activity and increased risk of cardiovascular death among patients with psoriatic arthritis","volume":"43","author":"Juneblad","year":"2016","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2019.01.002_bib11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/ard.52.3.174","article-title":"Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis","volume":"52","author":"Lehtinen","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib12","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1136\/ard.2011.151191","article-title":"Increased mortality in ankylosing spondylitis is related to disease activity","volume":"70","author":"Bakland","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/M14-2470","article-title":"Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study","volume":"163","author":"Haroon","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.berh.2019.01.002_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.atherosclerosis.2016.05.037","article-title":"2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice","volume":"252","author":"Piepoli","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.berh.2019.01.002_bib15","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American college of cardiology\/American heart association task force on practice guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.berh.2019.01.002_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/acr.22926","article-title":"Risk of cardiovascular morbidity in patients with psoriatic arthritis: a meta-analysis of observational studies","volume":"69","author":"Polachek","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2019.01.002_bib17","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/ard.2008.094839","article-title":"Cardiovascular morbidity in psoriatic arthritis","volume":"68","author":"Gladman","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib18","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/annrheumdis-2014-205675","article-title":"Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study","volume":"74","author":"Ogdie","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13075-017-1315-z","article-title":"Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study","volume":"19","author":"Bengtsson","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2019.01.002_bib20","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/acr.23567","article-title":"Incidence and prevalence of major adverse cardiovascular events in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis","volume":"70","author":"Lauper","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.berh.2019.01.002_bib21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.semarthrit.2018.03.005","article-title":"Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis , psoriatic arthritis , and psoriasis","volume":"48","author":"Cooksey","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.01.002_bib22","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/acr.22512","article-title":"Time trends in incidence, clinical features and cardiovascular disease in Ankylosing Spondylitis over 3 decades: a population based study","volume":"67","author":"Wright","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2019.01.002_bib23","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1002\/art.30581","article-title":"Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study","volume":"63","author":"Szabo","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.01.002_bib24","doi-asserted-by":"crossref","first-page":"e64155","DOI":"10.1371\/journal.pone.0064155","article-title":"Increased risk of ischemic heart disease in young patients with newly diagnosed ankylosing spondylitis \u2013 a population-based longitudinal follow-up study","volume":"8","author":"Huang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.berh.2019.01.002_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/annrheumdis-2014-206147","article-title":"Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study","volume":"75","author":"Essers","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib26","article-title":"Cardiovascular events in ankylosing spondylitis: a 2018 meta-analysis","author":"Mathieu","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/annrheumdis-2016-209315","article-title":"Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?","volume":"76","author":"Eriksson","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.semarthrit.2012.02.008","article-title":"No increased rate of acute myocardial infarction or stroke among patients with ankylosing spondylitis - a retrospective cohort study using routine data","volume":"42","author":"Brophy","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.01.002_bib29","article-title":"Risk of myocardial infarction and cerebrovascular accident in ankylosing spondylitis: a general population-based study","volume":"69","author":"So","year":"2017","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.01.002_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00296-013-2912-z","article-title":"Increased risk of stroke among patients with ankylosing spondylitis: a population-based matched-cohort study","volume":"34","author":"Keller","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2019.01.002_bib31","doi-asserted-by":"crossref","first-page":"e94027","DOI":"10.1371\/journal.pone.0094027","article-title":"Increased risk of ischemic stroke in young patients with ankylosing spondylitis: a population-based longitudinal follow-up study","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.berh.2019.01.002_bib32","first-page":"2","article-title":"Aortic involvement in ankylosing spondylitis","volume":"26","author":"Palazzi","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2019.01.002_bib33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.semarthrit.2014.02.004","article-title":"Diastolic left ventricular dysfunction in ankylosing spondylitis-A systematic review and meta-analysis","volume":"44","author":"Heslinga","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.01.002_bib34","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur Heart J - Cardiovasc Imaging"},{"key":"10.1016\/j.berh.2019.01.002_bib35","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/acr.20627","article-title":"Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis","volume":"63","author":"Husted","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2019.01.002_bib36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3899\/jrheum.160532","article-title":"The Association between obesity and clinical features of psoriatic arthritis: a case-control study","volume":"44","author":"Eder","year":"2017","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2019.01.002_bib37","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3899\/jrheum.160861","article-title":"The risk of developing diabetes mellitus in patients with psoriatic arthritis: a cohort study","volume":"44","author":"Eder","year":"2017","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2019.01.002_bib38","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/annrheumdis-2014-206824","article-title":"On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord-Tr\u00f8ndelag Health Study","volume":"75","author":"Gulati","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib39","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.22185","article-title":"Higher rates and clustering of abnormal lipids, obesity, and diabetes in psoriatic arthritis compared with rheumatoid arthritis","volume":"66","author":"Labitigan","year":"2014","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2019.01.002_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/acr.23094","article-title":"The incidence and management of cardiovascular risk factors in psoriatic arthritis and rheumatoid arthritis: a population-based study","volume":"69","author":"Jafri","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2019.01.002_bib41","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/acr.20408","article-title":"Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis","volume":"63","author":"Bremander","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2019.01.002_bib42","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/03009742.2013.822097","article-title":"A\u00a0nationwide population-based retrospective cohort study: increased risk of acute coronary syndrome in patients with ankylosing spondylitis","volume":"43","author":"Chou","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.berh.2019.01.002_bib43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00296-013-2927-5","article-title":"Ankylosing spondylitis and other inflammatory spondyloarthritis increase the risk of developing type 2 diabetes in an Asian population","volume":"34","author":"Chen","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2019.01.002_bib44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jbspin.2017.07.006","article-title":"Cardiovascular risk factors in patients with spondyloarthritis from Northern European and Mediterranean countries: an ancillary study of the ASAS-COMOSPA project","volume":"85","author":"L\u00f3pez-Medina","year":"2018","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.berh.2019.01.002_bib45","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.berh.2019.01.002_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/580404","article-title":"Psoriatic arthritis and diabetes: a population-based cross-sectional study","author":"Dreiher","year":"2013","journal-title":"Dermatol Res Pract"},{"key":"10.1016\/j.berh.2019.01.002_bib47","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/acr.23171","article-title":"Incidence and prevalence of cardiovascular risk factors among patients with rheumatoid arthritis, psoriasis, or psoriatic arthritis","volume":"69","author":"Radner","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2019.01.002_bib48","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/rheumatology\/ket343","article-title":"Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study","volume":"53","author":"Dubreuil","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2019.01.002_bib49","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1136\/ard.2009.125476","article-title":"The risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis","volume":"69","author":"Solomon","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib50","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the european society of hypertension (ESH) and of the european society of cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.berh.2019.01.002_bib51","first-page":"1269","author":"Whelton","year":"2018"},{"key":"10.1016\/j.berh.2019.01.002_bib52","first-page":"2167","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"33","author":"Han","year":"2006","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2019.01.002_bib53","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s10067-014-2743-7","article-title":"Prevalence of cardiovascular risk factors in patients with psoriatic arthritis","volume":"33","author":"Khraishi","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2019.01.002_bib54","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.semarthrit.2006.09.001","article-title":"Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis","volume":"36","author":"Kimhi","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.01.002_bib55","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1136\/annrheumdis-2011-201273","article-title":"Obesity and risk of incident psoriatic arthritis in US women Wenqing","volume":"71","author":"Li","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib56","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/rheumatology\/kew326","article-title":"The influence of obesity on response to tumour necrosis factor- a inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries","volume":"55","author":"H\u00f8jgaard","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2019.01.002_bib57","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2019.01.002_bib58","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12026-014-8595-z","article-title":"Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study","volume":"61","author":"Costa","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.berh.2019.01.002_bib59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/acr.20363","article-title":"Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis","volume":"63","author":"Mok","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2019.01.002_bib60","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3899\/jrheum.140021","article-title":"High prevalence of metabolic syndrome and of insulin resistance in psoriatic arthritis is associated with the severity of underlying disease","volume":"41","author":"Haroon","year":"2014","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2019.01.002_bib61","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10067-017-3975-0","article-title":"Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study","volume":"37","author":"Caso","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2019.01.002_bib62","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1016\/j.jacc.2013.11.003","article-title":"2013 AHA\/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American college of cardiology\/American heart association task force on practice guidelines","volume":"63","author":"Eckel","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.berh.2019.01.002_bib63","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/rheumatology\/kev392","article-title":"Impact of tobacco smoking on response to tumour necrosis factor-alpha inhibitor treatment in patients with ankylosing spondylitis: results from the Danish nationwide DANBIO registry","volume":"55","author":"Glintborg","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2019.01.002_bib64","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1136\/annrheumdis-2014-205389","article-title":"Association between tobacco smoking and response to tumour necrosis factor \u03b1 inhibitor treatment in psoriatic arthritis: results from the DANBIO registry","volume":"74","author":"H\u00f8jgaard","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib65","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.berh.2019.01.002_bib66","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jacc.2014.06.1186","article-title":"A\u00a0systematic examination of the 2013 ACC\/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease","volume":"64","author":"Karmali","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.berh.2019.01.002_bib67","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/acr.22536","article-title":"Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study","volume":"67","author":"Ernste","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2019.01.002_bib68","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00296-016-3614-0","article-title":"Cardiovascular risk profiles in a hospital-based population of patients with psoriatic arthritis and ankylosing spondylitis: a cross-sectional study","volume":"37","author":"Nissen","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2019.01.002_bib69","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3899\/jrheum.170025","article-title":"Underestimation of risk of carotid subclinical atherosclerosis by cardiovascular risk scores in patients with psoriatic arthritis: how far are we from the truth?","volume":"45","author":"Shen","year":"2018","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2019.01.002_bib70","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11926-012-0270-6","article-title":"Cardiovascular and cerebrovascular diseases in ankylosing spondylitis: current insights","volume":"14","author":"Nurmohamed","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.berh.2019.01.002_bib71","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.autrev.2011.05.022","article-title":"Atherosclerosis in psoriatic arthritis","volume":"10","author":"Ramonda","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2019.01.002_bib72","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13075-016-1074-2","article-title":"The impact of identifying carotid plaque on addressing cardiovascular risk in psoriatic arthritis","volume":"18","author":"Lucke","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2019.01.002_bib73","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/MD.0b013e3181c10773","article-title":"The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease","volume":"88","author":"Gonzalez-Juanatey","year":"2009","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.berh.2019.01.002_bib74","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/art.40389","article-title":"Higher coronary plaque burden in psoriatic arthritis is independent of metabolic syndrome and associated with underlying disease severity","volume":"70","author":"Szentpetery","year":"2018","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.01.002_bib75","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.106.628875","article-title":"Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis","volume":"115","author":"Lorenz","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.berh.2019.01.002_bib76","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/acr.20364","article-title":"Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis","volume":"63","author":"Mathieu","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2019.01.002_bib77","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3899\/jrheum.110792","article-title":"Assessment of preclinical atherosclerosis in patients with ankylosing spondylitis","volume":"39","author":"Hamdi","year":"2012","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2019.01.002_bib78","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","article-title":"Prediction of cardiovascular events and all-cause mortality with arterial stiffness. A systematic review and meta-analysis","volume":"55","author":"Vlachopoulos","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.berh.2019.01.002_bib79","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1093\/eurheartj\/ehl254","article-title":"Expert consensus document on arterial stiffness: methodological issues and clinical applications","volume":"27","author":"Laurent","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.berh.2019.01.002_bib80","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/rheumatology\/ken198","article-title":"Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease","volume":"47","author":"Mathieu","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2019.01.002_bib81","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1136\/annrheumdis-2014-206773","article-title":"CRP and ASDAS are associated with future elevated arterial stiffness, a risk marker of cardiovascular disease, in patients with ankylosing spondylitis: results after 5-year follow-up","volume":"74","author":"Berg","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib82","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10067-011-1892-1","article-title":"Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study","volume":"31","author":"Costa","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2019.01.002_bib83","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1093\/rheumatology\/kes213","article-title":"Increase in ventricular-arterial stiffness in patients with psoriatic arthritis","volume":"51","author":"Costa","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2019.01.002_bib84","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ijcard.2012.09.047","article-title":"Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis","author":"Ras","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.berh.2019.01.002_bib85","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/rheumatology\/kei145","article-title":"Impaired endothelial function in patients with ankylosing spondylitis","volume":"45","author":"Sari","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2019.01.002_bib86","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/art.22530","article-title":"Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors","volume":"57","author":"Gonzalez-Juanatey","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.01.002_bib87","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/1756-185X.12336","article-title":"Study of endothelial dysfunction in patients of psoriatic arthritis by flow mediated and nitroglycerine mediated dilatation of brachial artery","volume":"19","author":"Sharma","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib88","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrrheum.2013.91","article-title":"Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm","volume":"9","author":"Robertson","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2019.01.002_bib89","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/ard.59.11.904","article-title":"Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease","volume":"59","author":"Jones","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib90","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.semarthrit.2016.05.011","article-title":"Active peripheral inflammation is associated with pro-atherogenic lipid profile in psoriatic arthritis","volume":"46","author":"Shrestha","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.01.002_bib91","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.semarthrit.2008.06.001","article-title":"Asymptomatic hyperuricemia and serum uric acid concentration correlate with subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease","volume":"39","author":"Gonzalez-Gay","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.01.002_bib92","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs\u202f: meta-analyses of individual participant data from randomised trials","volume":"382","author":"Bhala","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2019.01.002_bib93","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bmj.c7086","article-title":"Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis","volume":"342","author":"Trelle","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.berh.2019.01.002_bib94","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","article-title":"Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis","volume":"375","author":"Nissen","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2019.01.002_bib95","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1136\/annrheumdis-2012-203137","article-title":"Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study","volume":"73","author":"Lindhardsen","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib96","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/ard.2007.076760","article-title":"Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients","volume":"68","author":"Goodson","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib97","first-page":"1","article-title":"Long-term frequent use of non-steroidal anti-inflammatory drugs might protect patients with ankylosing spondylitis from cardiovascular diseases: a nationwide case-control study","volume":"10","author":"Tsai","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.berh.2019.01.002_bib98","doi-asserted-by":"crossref","first-page":"e4792","DOI":"10.1097\/MD.0000000000004792","article-title":"Celecoxib and sulfasalazine had negative association with coronary artery diseases in patients with ankylosing spondylitis: a nation-wide, population-based case-control study","volume":"95","author":"Wu","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.berh.2019.01.002_bib99","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/acr.22555","article-title":"Safety of etoricoxib, celecoxib, and nonselective nonsteroidal antiinflammatory drugs in ankylosing spondylitis and other spondyloarthritis patients: a Swedish national population-based cohort study","volume":"67","author":"Kristensen","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2019.01.002_bib100","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/annrheumdis-2018-213089","article-title":"Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis","volume":"77","author":"Dubreuil","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib101","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ecl.2011.01.011","article-title":"Glucocorticoids and cardiovascular risk factors","volume":"40","author":"Strohmayer","year":"2011","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.berh.2019.01.002_bib102","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib103","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/art.34335","article-title":"Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study","volume":"64","author":"Chen","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.01.002_bib104","first-page":"2440","article-title":"Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab","volume":"33","author":"Spanakis","year":"2006","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2019.01.002_bib105","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.24492","article-title":"Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis","volume":"60","author":"Van Eijk","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.01.002_bib106","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3899\/jrheum.161418","article-title":"The Effects of 5-year etanercept therapy on cardiovascular risk factors in patients with psoriatic arthritis","volume":"44","author":"Agca","year":"2017","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2019.01.002_bib107","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/ard.2010.131359","article-title":"Tumour necrosis factor alpha blockade is associated with sustained regression of carotid intima-media thickness for patients with active psoriatic arthritis: a 2-year pilot study","volume":"70","author":"Tam","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib108","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/annrheumdis-2013-203934","article-title":"Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis","volume":"74","author":"Van Sijl","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib109","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ajh.2012.12","article-title":"Effect of 1-year Anti-TNF-\u03b1 therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study","volume":"25","author":"Angel","year":"2012","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.berh.2019.01.002_bib110","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/rheumatology\/ker434","article-title":"Anti-TNF-\u03b1 therapy may not improve arterial stiffness in patients with as: a 24-week follow-up","volume":"51","author":"Capkin","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2019.01.002_bib111","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/ard.2007.086777","article-title":"Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor \u03b1 blockade","volume":"68","author":"Van Eijk","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib112","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/annrheumdis-2015-208174","article-title":"Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study","volume":"75","author":"Molt\u00f3","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib113","first-page":"1","article-title":"Cardiovascular risk management in patients with active Ankylosing Spondylitis: a detailed evaluation","volume":"16","author":"Heslinga","year":"2015","journal-title":"BMC Muscoskelet Disord"},{"key":"10.1016\/j.berh.2019.01.002_bib114","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3899\/jrheum.170379","article-title":"Gaps in diagnosis and treatment of cardiovascular risk factors in patients with psoriatic disease: an international multicenter study","volume":"45","author":"Eder","year":"2018","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2019.01.002_bib115","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/art.34524","article-title":"Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease","volume":"64","author":"Semb","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.01.002_bib116","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/ard.2005.044503","article-title":"Statin therapy might be beneficial for patients with ankylosing spondylitis","volume":"65","author":"van Denderen","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib117","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1136\/annrheumdis-2016-209176","article-title":"Increased arterial wall inflammation in patients with ankylosing spondylitis is reduced by statin therapy","volume":"75","author":"van der Valk","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib118","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s10067-015-2912-3","article-title":"Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis","volume":"34","author":"Garg","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2019.01.002_bib119","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/art.39114","article-title":"Rosuvastatin-induced carotid plaque regression in patients with inflammatory joint diseases: the rosuvastatin in rheumatoid arthritis, ankylosing spondylitis and other inflammatory joint diseases study","volume":"67","author":"Rollefstad","year":"2015","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.01.002_bib120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-015-0795-y","article-title":"Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis: results from the RORA-AS statin intervention study","volume":"17","author":"Ikdahl","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2019.01.002_bib121","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1136\/annrheumdis-2017-211253","article-title":"Survival benefit of statin use in ankylosing spondylitis: a general population-based cohort study","volume":"76","author":"Oza","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib122","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults","volume":"311","author":"James","year":"2014","journal-title":"Jama"},{"key":"10.1016\/j.berh.2019.01.002_bib123","unstructured":"WHO. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. www.who.int\/diabetes\/publications\/report-hba1c_2011.pdf. 1\u201325."},{"key":"10.1016\/j.berh.2019.01.002_bib124","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/art.40726","article-title":"2018 American College of Rheumatology\/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis","volume":"71","author":"Singh","year":"2019","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.01.002_bib125","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1016\/j.jacc.2013.11.004","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American college of cardiology\/American heart association task force on practice guidelines and the obesity society","volume":"63","author":"Jensen","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.berh.2019.01.002_bib126","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.39573","article-title":"Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis","volume":"68","author":"Coates","year":"2016","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.01.002_bib127","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/annrheumdis-2012-202812","article-title":"Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor \u03b1 blockers","volume":"73","author":"Nicola","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2019.01.002_bib128","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/acr.21711","article-title":"Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis","volume":"65","author":"Nicola","year":"2013","journal-title":"Arthritis Care Res"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694219300026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694219300026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:19:41Z","timestamp":1761499181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694219300026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":128,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1521694219300026"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2019.01.002","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular morbidity and mortality in ankylosing spondylitis and psoriatic arthritis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2019.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}